Source link : https://newshealth.biz/health-news/adding-neoadjuvant-nivolumab-to-chemo-improved-survival-in-resectable-nsclc/
(MedPage Today) — CHICAGO — Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with chemotherapy alone for patients with resectable non-small cell lung cancer (NSCLC), the phase III CheckMate… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115875 Author : Publish date : 2025-06-03 16:38:00 Copyright for syndicated content belongs to the linked Source.
The post Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-03 16:38:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8